Can patients with pulmonary tuberculosis smoke?

Aug 08, 2022 Source: Cainiu Health
Dr. Guo Xiheng
Introduction
Patients with pulmonary tuberculosis must not smoke. Pulmonary tuberculosis is a respiratory disease in which the lung tissue has already been invaded and severely damaged by *Mycobacterium tuberculosis*. Tobacco contains numerous toxic substances, such as nicotine and tar. If patients with pulmonary tuberculosis continue smoking and fail to quit over the long term, their pulmonary function will deteriorate further. In severe cases, this may even lead to respiratory failure.

Some individuals are highly addicted to smoking; if they go a day without several cigarettes, they experience intense cravings and discomfort.

Tuberculosis (TB) is a relatively common disease in daily life. When diagnosed with pulmonary tuberculosis, in addition to receiving active treatment, patients must also pay attention to other aspects of self-care. So, can individuals with pulmonary tuberculosis smoke?

Can individuals with pulmonary tuberculosis smoke?

No, individuals with pulmonary tuberculosis must not smoke. Pulmonary tuberculosis is a respiratory disease caused by infection with Mycobacterium tuberculosis, which has already invaded and severely damaged lung tissue. Tobacco contains numerous toxic substances—including nicotine and tar—that further impair lung health. Continued smoking during active TB infection accelerates the decline in pulmonary function and, in severe cases, may even lead to respiratory failure. When nicotine enters the respiratory tract, it damages the ciliated epithelium of the respiratory mucosa and may stimulate hyperplasia of goblet cells. This results in enhanced glandular secretion, markedly increased sputum production, and worsening of coughing and expectoration symptoms.

Upon diagnosis of pulmonary tuberculosis, patients should promptly seek medical care at a hospital. Drug therapy remains the cornerstone of TB treatment. Because M. tuberculosis grows relatively slowly, treatment requires an extended duration, and patients must strictly adhere to their prescribed medication regimen under physician supervision. Common first-line anti-TB drugs include rifampicin and isoniazid. Second-line agents—such as sodium para-aminosalicylate and levofloxacin—are used when necessary. As many anti-TB medications carry potential hepatotoxicity, concurrent administration of hepatoprotective agents is recommended during treatment.

In daily life, patients should maintain a balanced, easily digestible diet, practice good personal hygiene, and engage in appropriate physical exercise. We hope this information proves helpful to you.